Marker Therapeutics Inc (MRKR)

[Phantom Lord]

I think it will be a different story once people actually see the data. It's one thing to hear the company say they are seeing efficacy. It's another to actually see the data. We should know if the presentation as accepted as an oral presentation or a poster presentation hopefully either tomorrow or Monday. I believe the 29th is when the companies are told if submissions were accepted. I'm hoping for an oral presentation but either way it should give us a good boost. Janney's price target was based solely on the AML trial and I don't think the pancreatic trial was on anyone's radar. That includes the large investors and analysts.